Wolfgang Miesbach: Individualized Hemostasis Care for Gender-Diverse Patients
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Gender diversity is no longer a niche topic in hemostasis care but part of everyday clinical reality.
At EAHAD2026, Nathan Connell presented ‘Gender diversity in haemostasis care: bridging gaps in an evolving landscape‘ and highlighted how gender‑affirming hormone therapy and surgeries intersect with venous thromboembolism (VTE) and bleeding risk. Current VTE risk scores do not account for gender‑affirming hormone therapy, yet simply withholding estrogen or testosterone out of fear of clots can cause substantial harm.
For clinical practice, this means moving towards truly individualized care: considering hormone formulation (oral vs transdermal), dose, route, duration, age, co‑morbidities, thrombophilia and co‑existing bleeding disorders, as well as peri‑operative management for gender‑affirming surgeries (e.g. mastectomy, hysterectomy, metoidioplasty, phalloplasty, facial feminization, breast augmentation, orchiectomy, vaginoplasty, vulvoplasty).
We need better data collection, reflection on unconscious bias in multidisciplinary teams, and research agendas built in partnership with the communities we serve.”
Find more posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation